← All indications
Adenocarcinoma, Clear Cell
An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)
Drugs by status
Phase 3 trials (6)
Phase 2 trials (8)
Phase 1 trials (9)
Other trials (5)
Organizations
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (33)
- Takeda
- Bristol-Myers Squibb
- Roche
- Genentech
- Plexxikon
- Celldex Therapeutics
- Syndax Pharmaceuticals
- Boehringer Ingelheim
- Brown University
- Canadian Cancer Trials Group
- Cathay General Hospital
- Cancer Research UK
- University of London
- Harvard University
- Nordic Society for Gynaecologic Oncology
- Radiation Therapy Oncology Group
- Rhode Island Hospital
- Southwest Oncology Group
- Thomas Jefferson University
- University of Glasgow
- University of Oklahoma
- University of Toronto
- Mayo Clinic
- Vanderbilt University
- National University of Singapore
- European Organisation for Research and Treatment of Cancer
- Technion University
- University of Texas at Houston
- ARCAGY-GINECO
- State University of New York, Buffalo
- +3 more
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (3)